Case report illustrates a long latency period for MPNST after radiotherapy, suggesting complex treatment needs.
A BSTRACT Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive sarcomas that may appear as late complications of radiotherapy. Here we report the case of a 54-year-old woman with a history of breast cancer treated with mastectomy and adjuvant chemoradiotherapy at the age of 29 in 1994, who developed an MPNST 26 years later. Electromyography and magnetic resonance imaging localized a mass along the right brachial plexus. Positron emission tomography/computed tomography showed a retroclavicular fluorodeoxyglucose-avid lesion (6.1 cm × 4.0 cm; SUV ma × 10.0) and a smaller focus in the low right neck (SUV ma × 4.8). Histopathology confirmed high-grade MPNST; immunohistochemistry demonstrated S-100/CD57/CD99 positivity with a Ki-67 index of ~70%. Genomic profiling identified a somatic CDKN2A deletion without actionable variants. The patient underwent resection, adjuvant doxorubicin, radiotherapy, pazopanib, and ultimately right upper-limb disarticulation, followed by systemic therapy, achieving complete metabolic response before nodal relapse at 44 months; care then transitioned to palliation. This case highlights the potential for very long latency of radiation-associated sarcoma, the complementary value of molecular profiling even when nonactionable, and the importance of multidisciplinary, multimodality management.
No takes yet. Share an insight, caveat, or question.
Espinoza et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: